Anoctamin 5 (ANO5, also known as TMEM16E) is a calcium-activated chloride channel encoded by the ANO5 gene located on chromosome 11p14.3. This protein belongs to the anoctamin family of membrane proteins that function as calcium-activated chloride channels (CaCCs) and phospholipid scramblases. While ANO5 is best characterized for its role in skeletal muscle disease, emerging research suggests potential implications in neuronal function and neurodegenerative processes.
Anoctamin 5 (ANO5, also known as TMEM16E) is a calcium-activated chloride channel encoded by the ANO5 gene located on chromosome 11p14.3. This protein belongs to the anoctamin family of membrane proteins that function as calcium-activated chloride channels (CaCCs) and phospholipid scramblases. While ANO5 is best characterized for its role in skeletal muscle disease, emerging research suggests potential implications in neuronal function and neurodegenerative processes.
Gene Information
Protein Structure and Function
ANO5 is a multipass membrane protein with eight predicted transmembrane domains. [@structure] The protein functions primarily as a calcium-activated chloride channel, though it also exhibits phospholipid scramblase activity. [@anoa] Unlike other anoctamin family members, ANO5 has relatively low chloride channel activity and may function primarily as a scramblase involved in membrane lipid organization.
Tissue Distribution
ANO5 is highly expressed in skeletal muscle and heart tissue, with lower expression in brain regions including the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum. [@anob] In the brain, ANO5 expression has been detected in [neurons](/entities/neurons) and glial cells, suggesting potential roles in neuronal signaling and homeostasis.
Disease Associations
Muscular Dystrophy
Mutations in ANO5 cause limb-girdle muscular dystrophy type 2L (LGMD2L) and distal myopathy, characterized by progressive weakness in proximal muscles. [@ano2011] These mutations typically result in loss of ANO5 protein function, leading to impaired calcium-dependent chloride transport in muscle fibers.
Neurodegenerative Disease Research
While direct associations between ANO5 and neurodegenerative diseases remain limited, several mechanisms suggest potential links:
Calcium Homeostasis: ANO5's role in calcium-activated chloride transport may influence neuronal calcium signaling, which is critical for synaptic function and vulnerable in Alzheimer's and Parkinson's diseases. [@calcium]
Muscle-Brain Axis: Given the emerging understanding of muscle-brain crosstalk in neurodegeneration, ANO5-related muscle dysfunction may impact neuronal health through systemic mechanisms. [@musclebrain2020]
Phospholipid Metabolism: ANO5's scramblase activity affects membrane lipid asymmetry, a process relevant to neuronal membrane trafficking and [autophagy](/entities/autophagy)—both compromised in neurodegenerative conditions. [@phospholipid2020]
Therapeutic Implications
Targeting ANO5 function remains challenging due to limited understanding of its neuronal roles. However, gene therapy approaches being developed for ANO5-related muscular dystrophy may have future applications in neuroprotection if neuronal functions are clarified. [@gene2019]
Research Directions
Further research is needed to:
Determine ANO5 expression and function in specific neuronal populations
Investigate potential interactions with known neurodegeneration pathways
Explore whether ANO5 variants modify risk for Alzheimer's or Parkinson's disease